When you perform a RCA and education is an action item as a result, what does that look like for your organization? How do you determine competency after?

Thank you,
Stacie Ethington, MSN, RN-BC
Medication Safety Nurse Specialist
Nebraska Medicine

Hello!

This is for any of you MSOs who also do drug diversion prevention.

We have budgeted and are planning to purchase the VeriLinkRx (narcotic waste testing) system sometime this fiscal year.

Rather than re-invent the wheel, I am wondering if anyone has implemented a similar system before? If so, does anyone have any policies, procedures, etc. around narcotic waste testing.

Any help would be greatly appreciated.

Thank you,
Lauren

Do you have inpatient behavioral health patients that are keeping their armbands for identification on their wrist? Please advise if you have a product that stays on, or what other processes you have implemented to continue safe patient identification for bedside barcoding and all other hospital processes for this patient population.

As you all know most CPOE for outpatient prescription writing out there are designed for adults(anything pediatric is always a custom job and is very expensive and takes long to build). Some systems are more intuitive than others in adapting pediatric order writing to accommodate mg/kg/dose and/or need for weights and instructions for more complex compounds. Others...not so much.

Hello . . . I am interested in opinions as to what professional habits may make a practitioner less likely to make a medication error in his or her professional practice. While understanding that most errors are ultimately system related, I would like to know if there are opinions as to what professional habits could add to system reliability to prevent errors. Some examples may be:

Our largest number of errors associated with nursing staff have to do with medications not being administered. Does anyone else have an issue with medications not being administered as ordered?
We are looking to do reeducation and want the providers to be notified when (certain) medications are not given. I was hoping to hear how other places tackle this - strict protocol for notifying providers per medication class or some other approach.
Thanks -
Maria Cumpston, PharmD, CPPS
Medication Safety Officer
WVU Medicine

Dear Colleagues:

As you know ISMP has long promoted that intravenous vincristine should only be given after dilution in a minibag and never by syringe. We recently called upon FDA to eliminate syringe administration in product labeling. Syringe administration remains in certain protocols around the world. In particular, syringes are used in infants and children in some locations, which continues to put patients at risk of injection into spinal fluid when mixed up with a drug intended for administration by that route. We are aware of 4 child deaths outside the US since January.

Another question regarding smart pumps:

Does anyone have a chemo drug library set up in their smart pumps? If so, how did you set it up?

We use Alaris pumps (obtained many years ago) and did not originally make a chemo library based on recommendations from the Alaris team. Rationale was that there are too many required concentrations of chemo drugs making building a library prohibitive. As the pumps have become more sophisticated, I am wondering what other institutions are doing in this high risk area.

Hello,

Does anyone have and is willing to share a monograph/algorithm/comparator chart of all available anti-emetics and their efficacy/safety in various populations (oncology, cardiology, pediatrics, etc.). Additionally, does it address use of and alternatives for promethazine as a sedative? I think it would be beneficial if ISMP/MSOS/ASHP? published this information so each institution would not have to do this work independently.

Thanks!
Rosemary

Hello,

We are revamping our smart pump processes and I’d like to know how other hospitals and health-systems function. My questions are below. Thank you in advance!